AYTU BIOPHARMA, INC Disposal Group, Including Discontinued Operation, Assets, Noncurrent
AYTU BIOPHARMA, INC (AYTU) had Disposal Group, Including Discontinued Operation, Assets, Noncurrent of $0 as of 2025-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent · last filed 2025-09-23
- 2025-06-30: Disposal Group, Including Discontinued Operation, Assets, Noncurrent $0.00.
- 2025-03-31: Disposal Group, Including Discontinued Operation, Assets, Noncurrent $0.00.
- 2024-12-31: Disposal Group, Including Discontinued Operation, Assets, Noncurrent $0.00.
- 2024-09-30: Disposal Group, Including Discontinued Operation, Assets, Noncurrent $0.00.
| Period end | Disposal Group, Including Discontinued Operation, Assets, Noncurrent |
|---|---|
| 2025-06-30 | $0.00 10-K · filed 2025-09-23 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-12 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 |
| 2024-06-30 | $44.00K 10-K · filed 2025-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |